ALZ.ST(ALZ.ST)
ALZ.ST
No analyst ratings available
No analyst price targets available for ALZ.ST
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $31M | $11M | $9M |
| Low | $31M | $11M | $9M |
| High | $31M | $11M | $9M |
| EBITDA Avg | $-8M | $-21M | $-23M |
| Low | $-8M | $-21M | $-23M |
| High | $-8M | $-21M | $-23M |
| EBIT Avg | $-27M | $-38M | $-38M |
| Low | $-27M | $-38M | $-38M |
| High | $-27M | $-38M | $-38M |
| Net Income Avg | $-27M | $-38M | $-38M |
| Low | $-27M | $-38M | $-38M |
| High | $-27M | $-38M | $-38M |
| EPS Avg | $-0.27 | $-0.38 | $-0.38 |
| Low | $-0.27 | $-0.38 | $-0.38 |
| High | $-0.27 | $-0.38 | $-0.38 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $21,663 |
| Low | $21,663 |
| High | $21,663 |
| EBITDA Avg | — |
| Low | — |
| High | — |
| EBIT Avg | — |
| Low | — |
| High | — |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |